학술논문
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
Document Type
Article
Author
Gerds, Aaron T ; Verstovsek, Srdan; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kiladjian, Jean-Jacques; Granacher, Nikki; Lee, Sung-Eun; Ocroteala, Luminita; Passamonti, Francesco; Harrison, Claire N; Oh, Stephen; Klencke, Barbara J; Yu, Jing; Donahue, Rafe; Kawashima, Jun; Mesa, Ruben
Source
In The Lancet Haematology September 2023 10(9):e735-e746
Subject
Language
ISSN
2352-3026